To investigate the transcriptional consequences of TLE3 abrogation in LNCaP prostate cancer cells, the transcriptomes of control and TLE3KO cells were compared (Figure 2—source data 1 and GSE130246). The gene discussed is TLE3; the disease is prostate carcinoma.